Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Biotalys NV ( (DE:86C) ) has shared an announcement.
Biotalys has announced the proposal to appoint Toni Bucci as an independent director to its Board of Directors, succeeding Markus Heldt. With over 30 years of experience in agriculture and biotechnology, Bucci’s expertise is expected to drive Biotalys’ growth and innovation in sustainable crop protection, aligning with the company’s mission to transform agriculture through protein-based biocontrols.
More about Biotalys NV
Biotalys is an Agricultural Technology (AgTech) company focused on developing protein-based biocontrol solutions for sustainable crop protection. Founded in 2013 as a spin-off from the VIB (Flanders Institute for Biotechnology), Biotalys aims to provide alternatives to conventional chemical pesticides, enhancing food safety and sustainability. The company, based in Ghent, Belgium, utilizes its AGROBODY™ technology platform to create a diverse pipeline of products addressing key crop pests and diseases.
YTD Price Performance: 8.92%
Average Trading Volume: 830
Technical Sentiment Signal: Sell
Current Market Cap: €133.8M
For a thorough assessment of 86C stock, go to TipRanks’ Stock Analysis page.